Disease Intelligence Center · Pandemic IV
Depressive & Anxiety Disorders
Mood symptoms are organized, not explained away. Sleep, stress, medications, endocrine factors, nutrient status, metabolic dysfunction, inflammation, substance use, social determinants and exposures are each examined as possible contributors, with validated screening and escalation built in.
Domain weighting
Organizational emphasisiWeightings describe where this framework directs attention for this condition. They are not a measure of how much any factor caused an individual case.
Root-cause chain
Each link carries its own evidence grade- Chronic sleep restriction→Mood symptom severityOA
Experimental sleep restriction worsens affect; insomnia treatment improves depressive symptoms.
Relationship: Randomized evidence
- Thyroid dysfunction→Depressive presentationBA
Hypothyroidism can present with depressed mood and reverses with treatment.
Relationship: Established causal
- Systemic inflammation→Anhedonia and fatigueIB
Cytokine-induced behavior change is well described; causal direction in primary depression is unsettled.
Relationship: Observational association
- B12, folate or iron deficiency→Fatigue and low moodNB
Deficiency states produce overlapping symptoms and should be corrected before attribution.
Relationship: Observational association
iDetection of an exposure does not establish that it caused a disease. This platform separates exposure, association, plausible mechanism, clinical evidence and demonstrated causation.
Fifth Estate considerations
Microbial ecologyGut–brain microbial hypotheses are presented as exploratory. No antimicrobial or probiotic protocol is framed as a treatment for a mood disorder.
Go deeper
TOBIN Intelligence LibraryThe full evidence review for Depressive & Anxiety Disorders: each mechanism by domain, what is established versus uncertain, related pandemics, relevant labs and how they move your scores.
Open the Depressive & Anxiety Disorders evidence reviewProtocol Fusion Engine
Six lanes · evidence grade and regulatory status on every entryConventional
First-line with durable effect across severities.
Caution: Escalate immediately for suicidal ideation or psychosis.
Guideline-supported for moderate to severe presentations.
Caution: Serotonin syndrome risk with combinations; bleeding risk with anticoagulants; pregnancy discussion required.
Functional
Insomnia treatment improves depressive outcomes.
Caution: Screen for sleep apnea and bipolar history before sleep deprivation strategies.
Orthomolecular
Removes reversible contributors to fatigue and low mood.
Caution: Treat measured deficiency only; not a replacement for mental-health care.
Traditional
Trials show benefit in mild depression.
Caution: Major CYP3A4 inducer: interacts with contraceptives, anticoagulants, antiretrovirals, immunosuppressants.
Energy / Physical
Energy medicine on Tayapulse →Effective in seasonal patterns and adjunctive in non-seasonal depression.
Caution: Mania risk in bipolar disorder; ophthalmologic caution in retinal disease.
iLanes are presented side by side so the difference in evidence strength is visible. Nothing here is a prescription, and interactions must be reviewed with your clinician and pharmacist.
iEnergy and physical modalities in this lane are explored further with Tayapulse. Evidence grade and regulatory status still apply: these are adjuncts used only where indicated, never cures or replacements for guideline care.
Diagnostics to consider
- · Validated depression and anxiety screening with risk assessment
- · TSH, CBC, ferritin, B12, folate, vitamin D
- · Medication and substance review
- · Sleep disorder screening
Monitoring
- · Screening score at each visit
- · Suicide-risk reassessment at every contact when flagged
- · Medication tolerability review
Prevention emphasis
- · Sleep regularity
- · Activity and daylight exposure
- · Social connection and support planning
- · Early treatment of thyroid and nutrient deficiencies